CURRENT PROJECTS – A randomised, double –blind, multicentre phase 3 study in patients with moderately to severely active Ulcerative colitis (UC) to compare the efficacy, safety and immunogenicity of PB016 and Entyvio for the induction and maintainance of clinical response and remission. (UCESIVE)
COMPLETED PROJECTS – A prospective, multicentre, open label, phase IV study to evaluate safety and efficacy profile of Infimab TM in patients with moderate to severe Crohns disease.